A man living with Fabry disease for more than two decades was found to have a second co-occurring genetic…
Articles by Marisa Wexler, MS
Protalix BioTherapeutics has requested a type A meeting with the U.S. Food and Drug Administration (FDA) to discuss a…
Family genetic testing can help to diagnose people with rare genetic conditions like Fabry disease, but there still are…
A new infusion protocol that gradually reduces the amount of time needed for the delivery of the Fabry disease…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Enzyme replacement therapy (ERT) may not effectively manage all aspects of Fabry disease in all patients, particularly when started…
Cysts in the kidneys are more common in people with Fabry disease than in other diseases that affect the…
A charitable program can help people with lysosomal storage disorders, such as Fabry disease, who live in underserved communities worldwide…
With data now reaching up to 3.5 years, benefits are continuing to be reported with the use of AVR-RD-01, …
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…